Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-28 @ 12:07 PM
Study NCT ID:
NCT06291103
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-04
First Post:
2024-02-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)
Sponsor:
University Hospital, Rouen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2031-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-26
First Submit QC Date:
None
Study First Post Date:
2024-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-26
Last Update Post Date:
2024-03-04
Last Update Post Date Type:
ACTUAL